For semaglutide users who list bloating as their primary complaint, this strain deserves priority
Semaglutide works by binding to GLP-1 receptors in the body, which increases insulin release and decreases glucagon levels
Over the past few years, Ozempic, Mounjaro, Zepbound, and similar GLP-1 Weight Loss medications have surged in popularity
Patients on the twice-daily exenatide were significantly less likely to experience treatment failure than those on the sulfonylurea glimepiride (41% versus 54%, HR 0.75, 95% CI 0.62 to 0.90,P=0.002), Baptist Gallwitz, MD, of Universitatsklinikum Tubingen in Tubingen, Germany, and colleagues reported online in The Lancet and at the American Diabetes Association meeting here
Patients can review official details through the FDA prescribing documentation
STEP UP: higher dose exploration The STEP UP trial investigated a higher dose of 7.2 mg weekly, three times the standard 2.4 mg dose